Allele Biotechnology And Pharmaceuticals, Inc.

San Diego, CA

UEI
VL99GKFNM1G3
CAGE
4TUH4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
6404 Nancy Ridge Dr, San Diego, CA 92121, USA
Founded
1999
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Single chain antibodies as renewable capture reagents HHSN271201100008C National Institute on Drug Abuse (NIH) $200,000
R & D-other sciences-ENG DEV HHSN261201000077C National Cancer Institute (NIH) $199,918
Sbir topic 269: development of novel protein expression technologies for glycosylated cancer related proteins HHSN261200900053C National Cancer Institute (NIH) $150,000
Small purchase data V5548Q0669 Veterans Integrated Service Network 19 (VHA) $295
Sbir phase I, topic 239 yeast single chain antibodies as capture reagents HHSN261200700040C National Cancer Institute (NIH) $150,000

Contract subawards

Prime contractor Prime award Amount Awarded
Albert Einstein College Of Medicine NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS YEAR 2 Subcontract 4-312-0218821 Initial Award 75N92023F00001 $500,000

Grant awards

Award Agency Obligated Awarded
Effective nanoantibodies as promising therapeutics for treating sepsis R43GM128549 National Institute of General Medical Sciences (NIH) $225,001
Human neural stem cells engineered against OA?-induced toxicity for cell therapy R43AG056186 National Institute on Aging (NIH) $225,000
Anti-RPS23RG1 nanoantibody as novel therapeutic and research reagents for alzheimers disease. R43AG055208 National Institutes of Health $225,000
Adaptable and automated large-scale manufacturing of ipsc-derived cell products R43HL130814 National Heart Lung and Blood Institute (NIH) $222,173
Generation and characterization of nanobodies against beta-amyloid R43AG052233 National Institutes of Health $224,999

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of California, San Diego Mod: 2,440,190.00 9/29/2026 Sub: 2,346,971.00 11/6/2025 TA1 Deliverables: M1.1 TA1.1 has completed the identification of three cell courses (iPSCs, Lucopack and… D25AC00432 $4,787,161

Quick answers

Is Allele Biotechnology And Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Allele Biotechnology And Pharmaceuticals, Inc.'s SAM.gov registration is active through April 21, 2027.

What is Allele Biotechnology And Pharmaceuticals, Inc.'s CAGE code?

Allele Biotechnology And Pharmaceuticals, Inc.'s CAGE code is 4TUH4, and its Unique Entity ID (UEI) is VL99GKFNM1G3.

What is Allele Biotechnology And Pharmaceuticals, Inc.'s most recent federal award?

Allele Biotechnology And Pharmaceuticals, Inc.'s most recent federal grant award is Effective nanoantibodies as promising therapeutics for treating sepsis (R43GM128549), from National Institute of General Medical Sciences (NIH), on September 1, 2018.

On GovTribe

See Allele Biotechnology And Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe